ASX/VLS (ASX/VLS)

Australian Securities Exchange: ASX/VLS · AUD

A$2.74

-0.01 (-0.4%)· Recorded snapshot

Market cap	148.1M
Revenue (ttm)	96M
Net income (ttm)	11.2M
EPS (ttm)	A$0.20
Shares out	54.1M
P/E (trailing)	13.9x
Dividend	A$0.14 (5.11%)
Volume	23,031
Beta	0.53

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 96M
Net income (ttm): 11.2M
EPS (ttm): A$0.20
P/E (trailing): 13.9x
Market cap: 148.1M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E13.9

P25 n/aP50 n/aP75 n/a

ROE20.6

P25 n/aP50 n/aP75 n/a

ROIC44.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.5%

Nasdaq Composite-2.4%

Dow Jones Industrial Average+1.8%

Russell 2000+1.8%

All ASX/VLS indicators

Market & fundamental data

Available fields

257

Groups with data

Currency

AUD

Showing 257 of 257 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-17
Employees	350
Enterprise value	AUD 116.5M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1947
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	AU000000VLS8
Last earnings date	2026-02-24
Last refreshed	2026-10-29
Market cap	AUD 148.1M
Next earnings date	2026-11-17
Price	AUD 2.74
Price currency	AUD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-29
Symbol	asx/VLS
Website	https://vitalifesciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	14.06x
Average P/E ratio (3Y)	12.9x
Average P/E ratio (5Y)	12.6x
Earnings yield	7.21%
EV/Earnings	10.44x
EV/EBIT	7.61x
EV/EBITDA	7.11x
EV/FCF	7.96x
EV/Sales	1.21x
FCF / EV yield	12.56%
FCF yield	9.87%
Graham number	2.09798
Graham upside	-23.43%
Lynch fair value	AUD 2.11
Lynch upside	-23.01%
P/(FCF - SBC) ratio	10.3x
P/(OCF - SBC) ratio	10.18x
P/B ratio	2.66x
P/E ratio	13.87x
P/FCF ratio	10.13x
P/OCF ratio	10.02x
P/S ratio	1.54x
Price / tangible book value	2.66x
Price/EBITDA ratio	9.34x
Sector forward P/E	33.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	15.94%
EBITDA margin	16.52%
Effective tax rate	29.13%
FCF margin	15.23%
Gross margin	62.81%
Operating margin	15.94%
Pretax margin	16.38%
Profit margin	11.61%
Profit per employee	AUD 31,869
Profitable quarters	33
Profitable years	16
Revenue per employee	AUD 274,374
ROA	12.34%
ROA (5Y)	13.18%
ROCE	26.61%
ROE	20.58%
ROE (5Y)	22.47%
ROIC	44.91%
ROIC (5Y)	44.76%
SBC / revenue	0.25%
Tax / revenue	4.77%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	19.39%
EPS growth (Q)	16.68%
EPS growth (QoQ)	3.21%
EPS growth 10Y	9.23%
EPS growth 3Y	13.49%
EPS growth 5Y	9.14%
EPS growth quarters	3
EPS growth years	1
FCF growth	59.44%
FCF growth (Q)	-20.95%
FCF growth (QoQ)	-53.58%
FCF growth 3Y	26.88%
FCF growth 5Y	16.56%
Gross profit growth	16.8%
Gross profit growth (Q)	11.99%
Gross profit growth 3Y	14.45%
Gross profit growth 5Y	14.25%
Net income growth	19.81%
Net income growth (Q)	14.86%
Net income growth (QoQ)	-0.64%
Net income growth 3Y	14.55%
Net income growth 5Y	10.68%
Net income growth quarters	3
Net income growth years	1
OCF growth	46.46%
OCF growth (Q)	-24.89%
OCF growth (QoQ)	-49.6%
OCF growth 10Y	17.99%
OCF growth 3Y	26.13%
OCF growth 5Y	16.36%
Operating income growth	22.72%
Operating income growth (Q)	19.48%
Operating income growth 3Y	12.16%
Operating income growth 5Y	12.52%
Revenue growth	12.19%
Revenue growth (Q)	6.06%
Revenue growth (QoQ)	1.21%
Revenue growth 10Y	9.58%
Revenue growth 3Y	11.87%
Revenue growth 5Y	13.86%
Revenue growth quarters	17
Revenue growth years	8

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -157,000
Depreciation and amortization	AUD 551,500
EBIT	AUD 15.3M
EBITDA	AUD 15.9M
EPS	AUD 0.20
FCF per share	AUD 0.27
Financing cash flow	AUD -10.2M
Free cash flow	AUD 14.6M
Free cash flow minus SBC	AUD 14.4M
Gross profit	AUD 60.3M
Income taxes	AUD 4.6M
Investing cash flow	AUD -157,000
Net borrowing	AUD -389,000
Net cash flow	AUD 4.3M
Net income	AUD 11.2M
Operating cash flow minus SBC	AUD 14.5M
Operating income	AUD 15.3M
Revenue	AUD 96M
Stock-based compensation	AUD 239,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.81
Book value per share	AUD 0.99
Debt / EBITDA	0.13
Debt / equity	0.04
Debt / FCF	0.15
Interest coverage	127.58
Long-term assets	AUD 15.7M
Long-term liabilities	AUD 1.8M
Net cash (debt)	AUD 31.5M
Net cash / market cap	21.29%
Net cash growth	16.19%
Net debt / EBITDA	-1.99
Net debt / equity	-0.57
Net debt / FCF	-2.16
Piotroski F-Score	6
Property, plant and equipment	AUD 12M
Shareholders' equity	AUD 55.7M
Tangible book value	AUD 55.8M
Tangible book value per share	AUD 0.99
Total assets	AUD 80.5M
Total cash	AUD 33.7M
Total debt	AUD 2.2M
Total liabilities	AUD 24.8M
WACC	7.14%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.24
Current assets	AUD 64.7M
Current liabilities	AUD 22.9M
Current ratio	2.82
Inventory turnover	2.44
Net working capital	AUD 8.6M
Quick ratio	2.1
Working capital	AUD 41.8M
Working capital turnover	2.37

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.37%
Dividend growth	31.82%
Dividend growth (10Y)	14.48%
Dividend growth (3Y)	32.38%
Dividend growth (5Y)	21.4%
Dividend growth years	5
Dividend payment date	2026-10-02
Dividend payment years	16
Dividend payout frequency	Semi-Annual
Dividend per share	AUD 0.14
Dividend yield	5.11%
Ex-dividend date	2026-09-18
FCF payout ratio	53.6%
Last dividend	AUD 0.05
Payout ratio	68.56%
Shareholder yield	4.74%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	82.67%
10Y return CAGR	11.01%
10Y total return	184.1%
150-day SMA	AUD 2.60
15Y price change	844.83%
15Y return CAGR	20.55%
15Y total return	1,549.18%
1D price change	-0.36%
1W price change	-1.08%
1W total return	-1.08%
1Y price change	16.1%
1Y return CAGR	22.8%
1Y total return	22.78%
20-day SMA	AUD 2.80
200-day SMA	AUD 2.60
3M price change	9.6%
3M total return	11.62%
3Y price change	52.22%
3Y return CAGR	20.88%
3Y total return	76.63%
50-day SMA	AUD 2.78
50-day SMA vs 200-day SMA	50over200
52-week high	AUD 2.90
52-week high date	2026-10-19
52-week low	AUD 2.27
52-week low date	2026-01-30
5Y price change	44.59%
5Y return CAGR	12.43%
5Y total return	79.66%
6M price change	6.62%
6M total return	8.58%
All-time high	AUD 2.90
All-time high date	2026-10-13
All-time low	AUD 0.05
All-time low date	2008-12-17
Average true range (ATR)	AUD 0.04
Average volume	21.1K
Beta (1Y)	0.05
Beta (2Y)	0.09
Beta (5Y)	0.53
Change from 52-week high	-5.52%
Change from 52-week low	20.71%
Change from all-time high	-5.52%
Change from all-time low	5,380%
Change from open	-2.14%
Day's gap	1.82%
Dollar volume	AUD 63,105
High price	AUD 2.80
Low price	AUD 2.74
Monthly RSI	62.3
Open price	AUD 2.80
Position in 52-week range	0%
Previous close	AUD 2.75
Price vs 150-day SMA	5.59%
Price vs 20-day SMA	-1.97%
Price vs 200-day SMA	5.55%
Price vs 50-day SMA	-1.4%
Relative volume	1.13
RSI	43.42
Sharpe ratio	0.45
Sharpe ratio (3Y)	0.77
Sharpe ratio (5Y)	0.79
Sortino ratio	0.85
Sortino ratio (3Y)	1.38
Sortino ratio (5Y)	1.37
Volume	23K
Weekly RSI	55.83
YTD price change	6.2%
YTD total return	12.31%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19.2M
Shares change (QoQ)	-3.7%
Shares change (YoY)	0.37%
Shares held by insiders	29.78%
Shares held by institutions	17.54%
Shares outstanding	54.1M

Deeper analysis on ASX/VLS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this ASX/VLS report

Is a complete ASX/VLS research report available?

No complete published report is available for asx/VLS (ASX/VLS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

148.1M

Revenue (ttm)

96M

Net income (ttm)

11.2M

EPS (ttm)

A$0.20

Shares out

54.1M

P/E (trailing)

13.9x

Dividend

A$0.14 (5.11%)

Volume

23,031

Beta

0.53

Metric

Value

Amount currency

AUD

Country

Australia

Country code

Earnings date

2026-11-17

Employees

350

Enterprise value

AUD 116.5M

Exchange

Australian Securities Exchange

Financial currency

AUD

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

December

Founded

1947

Industry

Drug Manufacturers - Specialty & Generic

Is primary listing

Yes

ISIN number

AU000000VLS8

Last earnings date

2026-02-24

Last refreshed

2026-10-29

Market cap

AUD 148.1M

Next earnings date

2026-11-17

Price

AUD 2.74

Price currency

AUD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-29

Symbol

asx/VLS

Website

https://vitalifesciences.com

Metric

Value

Average P/E ratio (10Y)

14.06x

Average P/E ratio (3Y)

12.9x

Average P/E ratio (5Y)

12.6x

Earnings yield

7.21%

EV/Earnings

10.44x

EV/EBIT

7.61x

EV/EBITDA

7.11x

EV/FCF

7.96x

EV/Sales

1.21x

FCF / EV yield

12.56%

FCF yield

9.87%

Graham number

2.09798

Graham upside

-23.43%

Lynch fair value

AUD 2.11

Lynch upside

-23.01%

P/(FCF - SBC) ratio

10.3x

P/(OCF - SBC) ratio

10.18x

P/B ratio

2.66x

P/E ratio

13.87x

P/FCF ratio

10.13x

P/OCF ratio

10.02x

P/S ratio

1.54x

Price / tangible book value

2.66x

Price/EBITDA ratio

9.34x

Sector forward P/E

33.91x

Metric

Value

EBIT margin

15.94%

EBITDA margin

16.52%

Effective tax rate

29.13%

FCF margin

15.23%

Gross margin

62.81%

Operating margin

15.94%

Pretax margin

16.38%

Profit margin

11.61%

Profit per employee

AUD 31,869

Profitable quarters

Profitable years

Revenue per employee

AUD 274,374

ROA

12.34%

ROA (5Y)

13.18%

ROCE

26.61%

ROE

20.58%

ROE (5Y)

22.47%

ROIC

44.91%

ROIC (5Y)

44.76%

SBC / revenue

0.25%

Tax / revenue

4.77%

Metric

Value

EPS growth

19.39%

EPS growth (Q)

16.68%

EPS growth (QoQ)

3.21%

EPS growth 10Y

9.23%

EPS growth 3Y

13.49%

EPS growth 5Y

9.14%

EPS growth quarters

EPS growth years

FCF growth

59.44%

FCF growth (Q)

-20.95%

FCF growth (QoQ)

-53.58%

FCF growth 3Y

26.88%

FCF growth 5Y

16.56%

Gross profit growth

16.8%

Gross profit growth (Q)

11.99%

Gross profit growth 3Y

14.45%

Gross profit growth 5Y

14.25%

Net income growth

19.81%

Net income growth (Q)

14.86%

Net income growth (QoQ)

-0.64%

Net income growth 3Y

14.55%

Net income growth 5Y

10.68%

Net income growth quarters

Net income growth years

OCF growth

46.46%

OCF growth (Q)

-24.89%

OCF growth (QoQ)

-49.6%

OCF growth 10Y

17.99%

OCF growth 3Y

26.13%

OCF growth 5Y

16.36%

Operating income growth

22.72%

Operating income growth (Q)

19.48%

Operating income growth 3Y

12.16%

Operating income growth 5Y

12.52%

Revenue growth

12.19%

Revenue growth (Q)

6.06%

Revenue growth (QoQ)

1.21%

Revenue growth 10Y

9.58%

Revenue growth 3Y

11.87%

Revenue growth 5Y

13.86%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

AUD -157,000

Depreciation and amortization

AUD 551,500

EBIT

AUD 15.3M

EBITDA

AUD 15.9M

EPS

AUD 0.20

FCF per share

AUD 0.27

Financing cash flow

AUD -10.2M

Free cash flow

AUD 14.6M

Free cash flow minus SBC

AUD 14.4M

Gross profit

AUD 60.3M

Income taxes

AUD 4.6M

Investing cash flow

AUD -157,000

Net borrowing

AUD -389,000

Net cash flow

AUD 4.3M

Net income

AUD 11.2M

Operating cash flow minus SBC

AUD 14.5M

Operating income

AUD 15.3M

Revenue

AUD 96M

Stock-based compensation

AUD 239,000

Metric

Value

Altman Z-Score

5.81

Book value per share

AUD 0.99

Debt / EBITDA

0.13

Debt / equity

0.04

Debt / FCF

0.15

Interest coverage

127.58

Long-term assets

AUD 15.7M

Long-term liabilities

AUD 1.8M

Net cash (debt)

AUD 31.5M

Net cash / market cap

21.29%

Net cash growth

16.19%

Net debt / EBITDA

-1.99

Net debt / equity

-0.57

Net debt / FCF

-2.16

Piotroski F-Score

Property, plant and equipment

AUD 12M

Shareholders' equity

AUD 55.7M

Tangible book value

AUD 55.8M

Tangible book value per share

AUD 0.99

Total assets

AUD 80.5M

Total cash

AUD 33.7M

Total debt

AUD 2.2M

Total liabilities

AUD 24.8M

WACC

7.14%

Metric

Value

Asset turnover

1.24

Current assets

AUD 64.7M

Current liabilities

AUD 22.9M

Current ratio

2.82

Inventory turnover

2.44

Net working capital

AUD 8.6M

Quick ratio

2.1

Working capital

AUD 41.8M

Working capital turnover

2.37

Metric

Value

Buyback yield / dilution

-0.37%

Dividend growth

31.82%

Dividend growth (10Y)

14.48%

Dividend growth (3Y)

32.38%

Dividend growth (5Y)

21.4%

Dividend growth years

Dividend payment date

2026-10-02

Dividend payment years

Dividend payout frequency

Semi-Annual

Dividend per share

AUD 0.14

Dividend yield

5.11%

Ex-dividend date

2026-09-18

FCF payout ratio

53.6%

Last dividend

AUD 0.05

Payout ratio

68.56%

Shareholder yield

4.74%

Metric

Value

10Y price change

82.67%

10Y return CAGR

11.01%

10Y total return

184.1%

150-day SMA

AUD 2.60

15Y price change

844.83%

15Y return CAGR

20.55%

15Y total return

1,549.18%

1D price change

-0.36%

1W price change

-1.08%

1W total return

-1.08%

1Y price change

16.1%

1Y return CAGR

22.8%

1Y total return

22.78%

20-day SMA

AUD 2.80

200-day SMA

AUD 2.60

3M price change

9.6%

3M total return

11.62%

3Y price change

52.22%

3Y return CAGR

20.88%

3Y total return

76.63%

50-day SMA

AUD 2.78

50-day SMA vs 200-day SMA

50over200

52-week high

AUD 2.90

52-week high date

2026-10-19

52-week low

AUD 2.27

52-week low date

2026-01-30

5Y price change

44.59%

5Y return CAGR

12.43%

5Y total return

79.66%

6M price change

6.62%

6M total return

8.58%

All-time high

AUD 2.90

All-time high date

2026-10-13

All-time low

AUD 0.05

All-time low date

2008-12-17

Average true range (ATR)

AUD 0.04

Average volume

21.1K

Beta (1Y)

0.05

Beta (2Y)

0.09

Beta (5Y)

0.53

Change from 52-week high

-5.52%

Change from 52-week low

20.71%

Change from all-time high

-5.52%

Change from all-time low

5,380%

Change from open

-2.14%

Day's gap

1.82%

Dollar volume

AUD 63,105

High price

AUD 2.80

Low price

AUD 2.74

Monthly RSI

62.3

Open price

AUD 2.80

Position in 52-week range

Previous close

AUD 2.75

Price vs 150-day SMA

5.59%

Price vs 20-day SMA

-1.97%

Price vs 200-day SMA

5.55%

Price vs 50-day SMA

-1.4%

Relative volume

1.13

RSI

43.42

Sharpe ratio

0.45

Sharpe ratio (3Y)

0.77

Sharpe ratio (5Y)

0.79

Sortino ratio

0.85

Sortino ratio (3Y)

1.38

Sortino ratio (5Y)

1.37

Volume

23K

Weekly RSI

55.83

YTD price change

6.2%

YTD total return

12.31%

Metric

Value

Float

19.2M

Shares change (QoQ)

-3.7%

Shares change (YoY)

0.37%

Shares held by insiders

29.78%

Shares held by institutions

17.54%

Shares outstanding

54.1M

ASX/VLS (ASX/VLS)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/VLS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/VLS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/VLS

Frequently asked questions

ASX/VLS (ASX/VLS)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/VLS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/VLS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/VLS

Frequently asked questions